Sales decline 7.65% to Rs 5889.93 crore
Net profit of Aurobindo Pharma declined 13.72% to Rs 696.99 crore in the quarter ended September 2021 as against Rs 807.83 crore during the previous quarter ended September 2020. Sales declined 7.65% to Rs 5889.93 crore in the quarter ended September 2021 as against Rs 6377.91 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales5889.936377.91 -8 OPM %19.9622.14 -PBDT1261.831450.32 -13 PBT967.621192.98 -19 NP696.99807.83 -14Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
